This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTSĬigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. Tri-VyLibra should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control. Tri-VyLibra is indicated for the treatment of moderate acne vulgaris in females at least 15 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche.
![tarina fe 1 20 eq tarina fe 1 20 eq](https://m.media-amazon.com/images/I/21Nm4Ju6cIL.jpg)
![tarina fe 1 20 eq tarina fe 1 20 eq](https://afaxyspharma.com/wp-content/uploads/Afaxys-Tarina-Fe-1_20-EQ-Outer-Carton-1-HiRes-removebg.png)
Tri-VyLibra is indicated for use by females of reproductive potential to prevent pregnancy. IMPORTANT SAFETY INFORMATION for Aubra EQ ® (levonorgestrel and ethinyl estradiol tablets, USP 0.1 mg/0.02 mg), Chateal EQ ® (levonorgestrel and ethinyl estradiol tablets, USP 0.15 mg/0.03 mg), Cyred EQ ® (desogestrel and ethinyl estradiol tablets, USP 0.15 mg/0.03 mg), Tarina Fe 1/20 EQ ® (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets, 1.0 mg/20 mcg and 75 mg), Tri-VyLibra ® (norgestimate and ethinyl estradiol tablets, USP 0.180 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.250 mg/0.035 mg) and Tri-VyLibra ® Lo (norgestimate and ethinyl estradiol tablets, USP 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, 0.250 mg/0.025 mg), and VyLibra ® (norgestimate and ethinyl estradiol tablets, USP 0.250 mg/0.035 mg) 1-7 INDICATIONSĪubra EQ, Chateal EQ, Cyred EQ, Tarina Fe 1/20 EQ, Tri-VyLibra Lo, and VyLibra are indicated for use by females of reproductive potential to prevent pregnancy.